Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma

Invest New Drugs. 1991 Nov;9(4):375-6. doi: 10.1007/BF00183586.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / secondary
  • Drug Evaluation
  • Female
  • Humans
  • Infusions, Intravenous
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Thioguanine / administration & dosage*
  • Thioguanine / adverse effects

Substances

  • Thioguanine